|
|
||||||||
Department of Neuroscience, University of Pittsburgh, Pittsburgh, Pennsylvania 15260
| |
ABSTRACT |
|---|
|
|
|---|
Increased dietary salt intake was used as a nonpharmacological tool to blunt hypotension-induced increases in plasma renin activity (PRA) in order to evaluate the contribution of the renin-angiotensin system (RAS) to hypotension-induced thirst. Rats were maintained on 8% NaCl (high) or 1% NaCl (standard) diet for at least 2 wk, and then arterial hypotension was produced by administration of the arteriolar vasodilator diazoxide. Despite marked reductions in PRA, rats maintained on the high-salt diet drank similar amounts of water, displayed similar latencies to drink, and had similar degrees of hypotension compared with rats maintained on the standard diet. Furthermore, blockade of ANG II production by an intravenous infusion of the angiotensin-converting enzyme inhibitor captopril attenuated the hypotension-induced water intake similarly in rats fed standard and high-salt diet. Additional experiments showed that increases in dietary salt did not alter thirst stimulated by the acetylcholine agonist carbachol administered into the lateral ventricle; however, increases in dietary salt did enhance thirst evoked by central ANG II. Collectively, the present findings suggest that hypotension-evoked thirst in rats fed a high-salt diet is dependent on the peripheral RAS despite marked reductions in PRA.
angiotensin II; water intake; blood pressure
| |
INTRODUCTION |
|---|
|
|
|---|
SYSTEMIC ADMINISTRATION of the selective arteriolar vasodilator diazoxide (DZX) decreases arterial blood pressure (AP), increases renin secretion from the kidney, and stimulates an increase in water intake in rats (1, 2, 17, 26). The increase in water intake has been attributed to the increase in circulating plasma levels of ANG II resulting from the increased renin secretion. Support for this conclusion arises from several lines of evidence. In particular, hypotension-induced water intake is attenuated or eliminated by bilateral nephrectomy (4, 8), by pharmacological blockade of ANG II production (2, 4, 11) or ANG II receptors (21), and by surgical destruction of subfornical organ, the central nervous system site at which peripheral ANG II exerts its dipsogenic action (21).
An alternative approach to reduce the activity of the peripheral renin-angiotensin system (RAS) is to increase dietary salt intake, as basal levels of plasma renin activity (PRA) are inversely related to dietary Na+ intake (12), and elevated salt intake has been demonstrated to blunt stimulated increases in renin secretion (12, 15, 16, 28). An advantage of manipulating the activity of the peripheral RAS by altering the amount of dietary salt is that this approach does not rely on pharmacological or surgical procedures. If hypotension-induced thirst is due to increased activation of the peripheral RAS, and elevated salt intake blunts stimulated increases in renin secretion, then rats maintained on a high-salt diet should exhibit a smaller increase in renin secretion and therefore ingest less water in response to decreased AP. To test this hypothesis, rats were maintained on 1% (standard) or 8% (high) NaCl diet for at least 2 wk, and water intakes were measured after administration of DZX. Initial studies indicated that increased dietary salt did suppress renin secretion but did not reduce thirst evoked by DZX-induced hypotension. This observation prompted further investigations to determine whether hypotension-induced thirst in rats maintained on high-salt diet was dependent on residual activation of the peripheral RAS.
| |
METHODS |
|---|
|
|
|---|
Animals. Adult male Sprague-Dawley rats (Harlan Laboratories, Indianapolis, IN) weighing 275-300 g were individually housed in a temperature-controlled room (22-23°C) with a 12:12-h light-dark cycle (lights on at 7 AM). Tap water and Purina 5001 Laboratory Chow (~1% NaCl) were available ad libitum except where noted.
Effect of standard and high-NaCl diet on hypotension-induced changes in water intake, AP, heart rate, and PRA. Rats were randomly assigned to one of two dietary groups. Each diet was based on a formulation containing 0.01% Na+ (TD=90228, Harlan Teklad, Madison, WI) and was supplemented either with 1% NaCl (n = 9) or 8% NaCl (n = 8). Rats were placed on the respective diet on day 0 and maintained on the diet for the remainder of the experiments. Body weights did not differ between the two groups before or during these experiments. As expected (14, 18), the daily water intakes of rats fed high-NaCl diet for 2 wk were significantly higher than those fed standard NaCl diet (94.2 ± 8.3 and 39.7 ± 3.1 ml, respectively; P < 0.01). Therefore, all experiments were conducted between 10 AM and 3 PM, while food was withheld and baseline water intakes of rats were comparably minimal (8% NaCl diet: 0.6 ± 0.2 ml/h; 1% NaCl diet: 0.2 ± 0.1 ml/h, n = 6 in each group).
On day 12, catheters were implanted in the left femoral artery (microrenathrane tubing, 0.012-in. ID and 0.025-in. OD, Braintree Scientific) and the left femoral and jugular veins (Silastic tubing, 0.020-in. ID and 0.037-in. OD, Fisher Scientific) while rats were anesthetized with halothane (2-3% in 100% O2). All catheters were tunneled subcutaneously to exit between the scapulas and were filled with heparinized saline (arterial, 1,000 U/ml; venous, 40 U/ml). Rats were then injected with antibiotic (Dual-cillin, 30,000 U, im) and were fit with an infusion harness (Harvard Apparatus) that allowed the catheters to pass outside of the cage while protected by a steel spring. Experiments began 2 days later. At least 1 h before experiments began, rats were weighed and returned to their cages. Food was removed, and a 50-ml burette containing tap water was placed on the cage. AP was recorded by connecting the arterial line to a Statham pressure transducer (Grass Instruments, Quincy, MA) and a polygraph chart recorder (Grass Instruments, model 7). The pulsatile AP signal was electronically filtered to obtain mean AP (MAP). Heart rate (HR) was obtained through a tachograph (Grass Instruments, model 7P44) triggered by the pulsatile AP. After a 20-min recording of MAP and HR, rats received one of three treatments: DZX (25 mg/kg iv) plus an infusion of isotonic saline (SLN, 1 ml/h), DZX (10 mg/kg iv) plus an infusion of the angiotensin-converting enzyme inhibitor captopril (CPT), or DZX (25 mg/kg iv) plus an infusion of CPT. CPT was administered initially as a bolus (3 mg/kg iv) through the jugular venous catheter and then was infused continuously for the remainder of the test (0.33 mg/min at 1 ml/h iv). Ten minutes later, rats were injected with DZX (10 or 25 mg/kg iv) or isotonic saline (1 ml/kg iv). These groups will be referred to by the dose of DZX plus the respective infusion (i.e., DZX-10 + CPT, DZX-25 + CPT, and DZX-25 + SLN). In similar treatment regimens, CPT has been demonstrated to block water intake evoked by several vasodilators in rats maintained on standard laboratory chow (2, 4, 19, 24). Because CPT treatment plus 25 mg/kg DZX in rats reduces MAP more than 25 mg/kg DZX alone (2), a lower dose of DZX (10 mg/kg iv) was administered together with CPT to produce similar levels of hypotension as those evoked by 25 mg/kg DZX + SLN. Each rat received the three treatments in random order, with experiments conducted every other day. Cumulative water intakes (±0.5 ml) were monitored every 15 min during the 90-min test, and latency to the first lick was also recorded. Urine outputs (±0.1 ml) were monitored during the 90-min test and were analyzed for Na+ and K+ concentrations (System E2A Electrolyte Analyzer, Beckman Instruments, Brea, CA). In addition, blood samples (0.4 ml) were collected from the arterial line into microcentrifuge tubes containing heparin (7 U) at baseline and 15 and 60 min after the injection of DZX. Samples were immediately centrifuged (10,000 g, 1 min). The first blood sample was replaced with an equal volume of isotonic saline, whereas subsequent samples were replaced with red blood cells from the previous sample resuspended in heparinized saline (40 U/ml). Plasma osmolality (Posmol) was measured from two 20-µl aliquots by freezing point depression using a micro-osmometer (model 3360, Advanced Instruments, Norwood, MA), and plasma protein levels were determined by refractometry. In addition, plasma aliquots (0.1 ml) were stored at
80°C until they
were analyzed for PRA as described previously (20, 27),
except that incubation times for generation of ANG I were 0 and 20 min.
The amount of ANG I detected at 0-min incubation was subtracted from
values obtained at 20-min incubation. To facilitate comparisons,
samples from animals fed one diet or the other but receiving the same
treatment (e.g., DZX + SLN) were analyzed in the same assay.
Effect of standard and high-NaCl diet on water intake evoked by centrally administered carbachol or ANG II. In these experiments, rats were maintained on standard or high-salt diet before water intake was evoked by centrally administered carbachol or ANG II. Rats were anesthetized with halothane (2-3% in 100% O2) and placed into a stereotaxic frame with the incisor bar positioned 3.3 mm below horizontal zero. Then a 26-gauge cannula was implanted into the lateral ventricle in each rat using the following coordinates in reference to bregma: 1.5 mm caudal, 1.7 mm lateral, and 4.5 mm below the dorsal surface of the skull. Cannulas were fixed to the skull with two screws and dental acrylic and were fitted with removable obturators that extended 0.5 mm beyond the tip of the guide cannula. Rats were treated with antibiotic (Dual-cillin; 30,000 U im) and allowed at least 4 days to recover. To accustom rats to the testing procedure, the obturator was loosened but not removed every other day. Proper placement of the cannulas was tested initially by examining water intakes in response to 5 ng of ANG II in 2 µl. Rats ingesting >3 ml of water during a 30-min test were used in subsequent experiments.
Rats with lateral cerebral cannulas were randomly assigned to a diet containing 1 or 8% NaCl (n = 7 for each group). Two weeks later, rats received an injection of either 15 ng of the acetylcholine agonist carbachol, 2.5 ng ANG II, or isotonic saline vehicle. Every rat received each injection once, in a randomized order, with experiments conducted every other day. To further examine the effect of changing dietary Na+ content on thirst stimulated by central ANG II, an additional group of rats was maintained on a diet containing 1% NaCl (n = 6) or 8% NaCl (n = 5) as described above. Two weeks later, rats received one of three doses of ANG II. These doses of ANG II were selected from preliminary experiments performed in rats maintained on standard Purina 5001 rat chow and provided a subthreshold dose (0.25 ng), midrange dose (2.5 ng), and a high dose (25 ng) of ANG II. Every rat received each dose of ANG II once, in a randomized order, with experiments conducted every other day. In these experiments, the obturator was removed and an injection cannula that extended 0.5 mm beyond the guide cannula was inserted into the guide cannula. The injection cannula was attached to PE-20 tubing and a 10-µl Hamilton syringe. The solution was injected, the injection cannula was removed and replaced by the obturator, and the rats were returned to their cages where a 50-ml burette of tap water was available but not food. Injection volumes for all experiments were 2 µl. Water intakes and urine outputs were monitored for 30 min, and urine was analyzed for Na+ and K+ concentrations as described above. At the conclusion of experiments, rats were anesthetized with halothane (3% in 100% O2), and 2 µl of 1% Fast Green was administered through the lateral ventricular cannula to verify its placement. A few minutes later, rats were decapitated and the brains were removed rapidly. In all rats of the present study, the dye had spread through the lateral, third, and fourth ventricles, thereby indicating that the cannula was properly placed in the lateral ventricle.Statistical analysis. All values are expressed as means ± SE. Water intake, MAP, HR, and PRA were analyzed by a two-way ANOVA with repeated measures. When significant F values were obtained, one-way ANOVAs were performed at each level of dietary salt or drug treatment followed by independent t-tests or Fisher's post hoc test, respectively. The repeated-measures variable was analyzed by paired t-tests and corrected by a layered Bonferroni analysis. PRA values were log-transformed before analysis. Plasma protein and Posmol were analyzed by a two-way ANOVA with repeated measures, as described for MAP and HR. Latency to drink, urine volume, and urinary Na+ and K+ excretion were analyzed by a two-way ANOVA followed by appropriate analysis as described above. Only rats that drank during the 90-min test were included in the analysis of latency to drink. In addition, the percentage of rats that drank was compared within each diet and treatment by a Fisher's exact test.
When water intake was plotted as a function of PRA values, the distribution of rats between groups was analyzed by a Fisher's Exact test (chi-square). The distribution of water intakes was analyzed with reference to a horizontal line drawn through the point representing the rat maintained on 8% NaCl diet that had the lowest water intake. The distribution of PRA values was analyzed with reference to a vertical line drawn through the point representing the rat maintained on 8% NaCl diet that had the largest PRA value. Water intakes for intracerebroventricular experiments were analyzed by a two-way ANOVA with repeated measures followed by post hoc analysis as described above for MAP and HR. Urine volume and urinary Na+ and K+ excretion were analyzed as described for water intakes.| |
RESULTS |
|---|
|
|
|---|
Effect of standard and high-NaCl diet on hypotension-induced
drinking responses, MAP, HR, and PRA values.
Rats maintained on diets containing 1 or 8% NaCl ingested similar
amounts of water throughout the 90-min test after systemic administration of DZX (25 mg/kg iv) (Fig.
1A). Every DZX-25 + SLN rat drank,
and the latencies to drink were similar in the two groups (Table
1). In addition, DZX-25 + SLN
significantly decreased MAP from baseline values in both groups, and
MAP values were similar in rats maintained on the two diets at every
time throughout the test period (Fig. 1B).
|
|
|
|
|
Effect of CPT infusion on hypotension-induced drinking responses,
MAP, HR, and PRA values in rats maintained on standard and high-NaCl
diets.
To determine whether the increase in water intake after DZX
administration is due to increased activity of the RAS, ANG II production was blocked pharmacologically by an intravenous infusion of
CPT in rats fed either 1 or 8% NaCl. DZX-25 + CPT rats maintained on a diet containing 1% NaCl ingested less water and had a longer latency to drink than DZX-25 + SLN rats (Fig.
3A, Table 1). However, these
DZX-25 + CPT rats had a significantly lower MAP than DZX-25 + SLN rats throughout the test (Fig. 3B). Thus it is important to note that DZX-10 + CPT rats ingested significantly less water and had significantly longer latencies to drink than DZX-25 + SLN
rats (Fig. 3A, Table 1) despite similar levels of MAP (Fig. 3B). Furthermore, a smaller percentage of DZX-10 + CPT
rats drank compared with DZX-25 + SLN rats (Table 1). On the other
hand, water intakes and latencies to drink were not significantly
different between DZX-10 + CPT and DZX-25 + CPT rats during
the 90-min test (Fig. 3A) despite substantial differences in
MAP (Fig. 3B).
|
Effect of standard and high-NaCl diet on water intake evoked by
centrally administered carbachol, ANG II, and isotonic saline.
In these experiments, rats were fed 1 or 8% NaCl for at least 2 wk and
then received an injection of carbachol, ANG II, or isotonic saline
into the lateral cerebral ventricle. Water intake in response to
carbachol was not significantly different between rats in the two
groups (Fig. 4A), whereas rats
ingested significantly more water in response to 2.5 ng ANG II when the
diet contained 8% NaCl instead of 1% NaCl (Fig. 4A).
Injection of isotonic saline had no effect in either group (Fig.
4A). In addition, there were no significant differences in
urinary volume or in urine Na+ and K+ excretion
in response to carbachol, ANG II, or SLN between rats maintained on 1 and 8% NaCl diets (data not shown).
|
| |
DISCUSSION |
|---|
|
|
|---|
Increases in dietary salt are known to reduce basal renin secretion (12) and blunt stimulated increases in renin secretion (15, 16, 28). Consequently, rats maintained on high-NaCl diet should have smaller increases in renin secretion during arterial hypotension and therefore smaller drinking responses, because the induced thirst appears to be dependent on activation of the peripheral RAS (2-4, 8, 11, 26). The present findings demonstrate that an elevation in dietary NaCl did markedly attenuate the increase in PRA stimulated by DZX-induced hypotension in rats. However, increased dietary salt did not affect the latency to drink or the induced increase in water intake. These surprising results provoked further consideration of the stimulus for thirst under the present experimental conditions.
These findings cannot be explained by differences in the degree of hypotension between the two groups or by differences in Posmol, plasma protein, or urinary output. Nor is it likely that DZX-treated rats maintained on high-salt diet were less thirsty but nonetheless drank more water because ingested water leached NaCl from gastric chyme en route to the intestines, thereby making the water less hydrating. After all, the latencies to drink of these animals were similar to those of rats maintained on standard diet, which suggests that the induced thirst in the two groups was similar. Furthermore, rats given carbachol centrally did not drink more water when maintained on high-salt diet instead of standard diet, which suggests that maintenance on high-salt diet does not invariably lead to the overconsumption of water.
An alternative hypothesis is that drinking elicited by DZX-evoked hypotension in rats maintained on a high-salt diet occurs independently of the peripheral RAS. To test this notion, ANG II production was blocked pharmacologically by CPT, an angiotensin-converting enzyme inhibitor, in DZX-treated rats maintained on high-salt diet. Previous studies have demonstrated that CPT treatment markedly attenuates hypotension-induced thirst in rats fed standard laboratory diet (2-4, 11). The present findings confirm and extend these observations by indicating that the infusion of CPT nearly eliminated the increase in water intake and also greatly lengthened the latency to drink in rats maintained on a diet containing 1% NaCl. A more striking effect, however, was that the infusion of CPT similarly inhibited drinking behavior in rats maintained on high-salt diet. Although CPT may have other actions in addition to the inhibition of ANG II synthesis (29), those actions probably are not responsible for its suppressive effect on hypotension-evoked thirst because replacement of circulating ANG II levels by an intravenous infusion of ANG II has been reported to restore drinking behavior in DZX + CPT rats (2). Furthermore, CPT likely did not inhibit hypotension-evoked thirst by generally disrupting drinking behavior, because CPT administered alone or in combination with DZX does not interfere with drinking stimulated by intravenous infusion of hypertonic saline (2, 19) or ANG II (2, 24). Moreover, a high dose of CPT that blocked drinking stimulated by renin or ANG I administered into the lateral ventricle did not affect the increase in water intake that occurred when ANG II was given into the lateral ventricle or peripherally (5). These results indicate that CPT treatment does not interfere with the mechanisms necessary for the dipsogenic actions of peripheral ANG II. Thus drinking behavior during DZX-evoked hypotension in rats maintained on diets containing either 1 or 8% NaCl appears to be mediated by the peripheral RAS despite large differences in PRA.
The precise relation between peripheral ANG II and thirst in rats has never been defined under conditions of arterial hypotension. Because circulating ANG II was not measured in the present experiments, it is not even certain that the relatively low PRA values observed in rats fed high-salt diet reflect a suppressive effect of dietary salt on circulating ANG II levels. However, others have reported that circulating ANG II levels do decrease in response to increased dietary salt (7, 13). If PRA values actually reflect circulating levels of ANG II in the present animals, then the modest increase in PRA values in DZX-treated rats maintained on high-salt diet probably is not large enough to stimulate thirst in rats maintained on a standard salt diet. Thus, assuming that circulating ANG II does provide the stimulus of thirst in DZX-treated rats maintained on high-salt diet and that circulating levels of ANG II are much lower in these animals than in rats maintained on standard diet, then the drinking response of rats fed 8% NaCl diet would appear to reflect an increase in the dipsogenic potency of peripheral ANG II.
Interestingly, rats fed 8% NaCl ingested much more water than rats fed 1% NaCl when ANG II, but not carbachol, was injected into the lateral cerebral ventricle. In fact, rats fed a high-salt diet drank as much water when given 0.25 ng of ANG II centrally as rats fed a 1% NaCl diet and given 2.5 ng ANG II. These observations suggest a 10-fold increase in the dipsogenic potency of central ANG II in rats fed a high-salt diet. Whether the same is true of circulating ANG II awaits further investigation. In this regard, we did not infuse ANG II intravenously in the present experiments because the obtained results may have been very difficult to interpret. Intravenous ANG II stimulates the ingestion of water but also provides an inhibitory signal for thirst due to the associated increase in AP (1, 6, 19, 24, 25). Because increases in dietary salt enhance the pressor activity of acutely administered peripheral ANG II (22, 23) and also alter baroreflex function (9, 10), an increased dipsogenic potency of intravenous ANG II in rats fed a high-salt diet would be confounded by cardiovascular changes and their impact on water intake.
The mechanism(s) underlying the enhanced dipsogenic response to the circulating ANG II may consist of, but are not limited to, an enhanced cellular response to peripheral ANG II and/or an enhanced response of the central neural circuits mediating ANG II-induced water intake. Consistent with these possibilities, it is interesting to note that the percent change in PRA values in response to DZX-induced hypotension is not significantly different in rats maintained on standard and high-salt diets. Therefore, it is possible that the change in circulating ANG II levels relative to circulating basal levels is more relevant as a stimulus of thirst than the absolute values of circulating ANG II. Clearly, further investigation is needed to address these issues.
In summary, the present findings demonstrate that increases in dietary salt intake markedly blunt hypotension-induced increases in PRA yet do not affect the induced thirst. Furthermore, hypotension-induced thirst appears to be mediated by the peripheral RAS in rats maintained on high-salt diet, as blockade of ANG II synthesis by CPT attenuated the increase in water intake. These results suggest that increasing dietary salt intake is associated with enhanced dipsogenic effects of circulating ANG II. Rats fed a high-salt diet were not more responsive to carbachol administered centrally, indicating that increased dietary salt does not enhance thirst in response to all treatments. Collectively, these observations suggest that hypotension-induced thirst in rats fed high-salt diet remains dependent on activation of the peripheral RAS, despite markedly low PRA. The basis of the elevated water intake in these conditions remains to be determined. More generally, it seems clear that investigations in which dietary salt intake is altered to affect the activity of the peripheral RAS must allow for the possibility that postsynaptic changes in ANG II-sensitive neurons or pathways may compensate for induced changes in circulating ANG II levels.
| |
ACKNOWLEDGEMENTS |
|---|
We thank T. McNelis for technical assistance.
This research was supported by National Institutes of Health Grants HL-55687 (A. F. Sved) and MH-25140 (E. M. Stricker). S. D. Stocker was supported by an Andrew Mellon Predoctoral Fellowship.
Present address for S. D. Stocker: Dept. of Physiology, Univ. of Texas Health Science Center at San Antonio, 7703 Floyd Curl Dr., San Antonio, TX 78229 (E-mail: stocker{at}uthscsa.edu).
| |
FOOTNOTES |
|---|
Address for reprint requests and other correspondence: A. F. Sved, Dept. of Neuroscience, Univ. of Pittsburgh, 446 Crawford Hall, Pittsburgh, PA 15260 (E-mail: sved{at}bns.pitt.edu).
The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
First published March 6, 2003;10.1152/ajpregu.00658.2002
Received 25 October 2002; accepted in final form 18 February 2003.
| |
REFERENCES |
|---|
|
|
|---|
1.
Evered, MD.
Investigating the role of angiotensin II in thirst: interactions between arterial pressure and the control of drinking.
Can J Physiol Pharmacol
70:
791-797,
1992[ISI][Medline].
2.
Evered, MD.
Relationship between thirst and diazoxide-induced hypotension in rats.
Am J Physiol Regul Integr Comp Physiol
259:
R362-R370,
1990
3.
Evered, MD,
and
Robinson MM.
Increased or decreased thirst caused by inhibition of angiotensin-converting enzyme in the rat.
J Physiol
348:
573-588,
1984
4.
Evered, MD,
and
Robinson MM.
The renin-angiotensin system in drinking and cardiovascular responses to isoprenaline in the rat.
J Physiol
316:
357-367,
1981
5.
Evered, MD,
Robinson MM,
and
Richardson MA.
Captopril given intracerebroventricularly, subcutaneously or by gavage inhibits angiotensin-converting enzyme activity in the rat brain.
Eur J Pharmacol
68:
443-449,
1980[ISI][Medline].
6.
Evered, MD,
Robinson MM,
and
Rose PA.
Effect of arterial pressure on drinking and urinary responses to angiotensin II.
Am J Physiol Regul Integr Comp Physiol
254:
R69-R74,
1988
7.
Fox, J,
Guan S,
Hymel AA,
and
Navar LG.
Dietary Na and ACE inhibition effects on renal tissue angiotensin I and II and ACE activity in rats.
Am J Physiol Renal Fluid Electrolyte Physiol
262:
F902-F909,
1992
8.
Houpt, KA,
and
Epstein AN.
The complete dependence of
-adrenergic drinking on the renal dipsogen.
Physiol Behav
7:
897-902,
1971[Medline].
9.
Huang, BS,
and
Leenen FH.
Dietary Na and baroreflex modulation of blood pressure and RSNA in normotensive vs. spontaneously hypertensive rats.
Am J Physiol Heart Circ Physiol
266:
H496-H502,
1994
10.
Ito, S,
Gordon FJ,
and
Sved AF.
Dietary salt intake alters cardiovascular responses evoked from the rostral ventrolateral medulla.
Am J Physiol Regul Integr Comp Physiol
276:
R1600-R1607,
1999
11.
Katovich, MJ,
Barney CC,
Fregly MJ,
and
McCaa RE.
Effect of an angiotensin converting enzyme inhibitor (SQ 14,225) on
-adrenergic and angiotensin-induced thirsts.
Eur J Pharmacol
56:
123-130,
1979[ISI][Medline].
12.
Keeton, TK,
and
Campbell WB.
The pharmacologic alteration of renin release.
Pharmacol Rev
32:
81-227,
1980[ISI][Medline].
13.
Krieger, JE,
Liard JF,
and
Cowley AW, Jr.
Hemodynamics, fluid volume, and hormonal responses to chronic high-salt intake in dogs.
Am J Physiol Heart Circ Physiol
259:
H1629-H1636,
1990
14.
Osborn, JW,
and
Provo BJ.
Salt-dependent hypertension in the sinoaortic-denervated rat.
Hypertension
19:
658-662,
1992
15.
Pettinger, WA,
Keeton TK,
Campbell WB,
and
Harper DC.
Evidence for a renal alpha-adrenergic receptor inhibiting renin release.
Circ Res
38:
338-346,
1976
16.
Pettinger, WA,
Marchelle M,
and
Augusto L.
Renin suppression by DOC and NaCl in the rat.
Am J Physiol
221:
1071-1074,
1971
17.
Pratz, J,
Mondot S,
Montier F,
and
Cavero I.
Effects of the K+ channel activators, RP 52891, cromakalim and diazoxide, on the plasma insulin level, plasma renin activity and blood pressure in rats.
J Pharmacol Exp Ther
258:
216-222,
1991
18.
Richter, CP,
and
Mosier HDJ
Maximum sodium chloride intake and thirst in domesticated and wild Norway rats.
Am J Physiol
176:
213-222,
1954
19.
Robinson, MM,
and
Evered MD.
Pressor action of intravenous angiotensin II reduces drinking response in rats.
Am J Physiol Regul Integr Comp Physiol
252:
R754-R759,
1987
20.
Schreihofer, AM,
Hoffman GE,
and
Sved AF.
The kidneys stimulate vasopressin release during hemorrhage in rats with chronic NTS lesions.
Am J Physiol Regul Integr Comp Physiol
272:
R1540-R1551,
1997
21.
Simpson, JB,
Epstein AN,
and
Camardo JS, Jr.
Localization of receptors for the dipsogenic action of angiotensin II in the subfornical organ of rat.
J Comp Physiol Psychol
92:
581-601,
1978[ISI][Medline].
22.
Slack, BL,
and
Ledingham JM.
The influence of sodium intake on the pressor response to angiotensin II in the unanaesthetized rat.
Clin Sci Mol Med
50:
285-291,
1976[ISI][Medline].
23.
Smyth, DD,
and
Fung HY.
Indomethacin and angiotensin II pressor responsiveness: importance of dietary sodium.
Eur J Pharmacol
102:
55-61,
1984[ISI][Medline].
24.
Stocker, SD,
Stricker EM,
and
Sved AF.
Acute hypertension inhibits thirst stimulated by ANG II, hyperosmolality, or hypovolemia in rats.
Am J Physiol Regul Integr Comp Physiol
280:
R214-R224,
2001
25.
Stocker, SD,
Stricker EM,
and
Sved AF.
Arterial baroreceptors mediate the inhibitory effect of acute increases in arterial blood pressure on thirst.
Am J Physiol Regul Integr Comp Physiol
282:
R1718-R1729,
2002
26.
Stocker, SD,
Sved AF,
and
Stricker EM.
Role of renin-angiotensin system in hypotension-evoked thirst: studies with hydralazine.
Am J Physiol Regul Integr Comp Physiol
279:
R576-R585,
2000
27.
Sved, AF.
Peripheral pressor systems in hypertension caused by nucleus tractus solitarius lesions.
Hypertension
8:
742-747,
1986
28.
Vollmer, RR,
Bush EN,
and
Abukhres MM.
Influence of dietary sodium on renin angiotensin system involvement in sodium nitroprusside hypotension in conscious rats.
J Pharmacol Exp Ther
216:
580-585,
1981
29.
Zusman, RM.
Renin- and non-renin-mediated antihypertensive actions of converting enzyme inhibitors.
Kidney Int
25:
969-983,
1984[ISI][Medline].
This article has been cited by other articles:
![]() |
P. J. Mueller, M. J. Sullivan, R. R. Grindstaff, J. T. Cunningham, and E. M. Hasser Regulation of plasma vasopressin and renin activity in conscious hindlimb-unloaded rats Am J Physiol Regulatory Integrative Comp Physiol, July 1, 2006; 291(1): R46 - R52. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. D. Stocker, J. C. Schiltz, and A. F. Sved Acute increases in arterial blood pressure do not reduce plasma vasopressin levels stimulated by angiotensin II or hyperosmolality in rats Am J Physiol Regulatory Integrative Comp Physiol, July 1, 2004; 287(1): R127 - R137. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |